about
Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosisUnexpected protective role for Toll-like receptor 3 in the arterial wallAnti-TNF therapy: past, present and futureBiomechanical factors and macrophages in plaque stabilityNovel methodologies for biomarker discovery in atherosclerosisDistinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAPRole of interleukin-1beta in postoperative cognitive dysfunction.Intimal hyperplasia following implantation of helical-centreline and straight-centreline stents in common carotid arteries in healthy pigs: influence of intraluminal flowTumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive declineProteomics of acute coronary syndromes.Innate immunity and monocyte-macrophage activation in atherosclerosis.Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis.T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases.Dominant Suppression of Inflammation via Targeted Mutation of the mRNA Destabilizing Protein Tristetraprolin.TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissuesNovel role of ADAMTS-5 protein in proteoglycan turnover and lipoprotein retention in atherosclerosis.What causes acute coronary syndromes? Applying Koch's postulates.Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug developmentToll-like receptors in atherosclerosisThe inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus.The use of contrast enhanced ultrasound in carotid arterial disease.Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaquesThe expression and functions of toll-like receptors in atherosclerosis.Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets.Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis.The tolls and dangers of atherosclerotic disease.Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden.Inflammatory predictors of mortality in the Scandinavian Simvastatin Survival Study.Toll-like receptors and macrophage activation in atherosclerosis.Toll-like receptors in atherosclerosis: a 'Pandora's box' of advances and controversies.Macrophages and dendritic cells: the usual suspects in atherogenesis.Imaging vulnerable plaques by targeting inflammation in atherosclerosis using fluorescent-labeled dual-ligand microparticles of iron oxide and magnetic resonance imaging.Danger signals in cardiovascular disease.Stimulation of the α7 nicotinic acetylcholine receptor protects against neuroinflammation after tibia fracture and endotoxemia in miceAnti-TNF Therapy.Biomechanical factors in atherosclerosis: mechanisms and clinical implications.Imaging of the vulnerable carotid plaque: biological targeting of inflammation in atherosclerosis using iron oxide particles and MRI.Low shear stress induces M1 macrophage polarization in murine thin-cap atherosclerotic plaques.Interleukin-6 and microRNA profiles induced by oral bacteria in human atheroma derived and healthy smooth muscle cells.Role of inflammation in the pathogenesis of unstable coronary artery disease.
P50
Q24568066-F7CBD4D6-C1DA-457C-89FC-20AF1C9C69D4Q24624935-491FF07C-C3CA-43F5-982D-8C46F7E63740Q26997311-80E2D5C1-4E01-4F8A-8341-2A02176B2367Q27693877-2BB69C62-36D4-4225-9901-93B455154154Q28088373-EFC7B06E-F946-4901-971B-0364D7F40CB0Q28591643-4450F164-8158-4417-A9CE-70B106C99D15Q30385588-A9DA77A5-62A5-4239-A2AD-4687AC5CC4EFQ30554411-61C43569-F8FF-44A4-B6CF-4A42148B7427Q34377379-FE31B1E4-DCA5-48FC-96E0-AD8BC01D8483Q34975175-61A4F321-8FA0-40F9-9653-D851DA4A0146Q34980214-8BEAA71E-3BBD-4145-8A15-9355F90F2417Q35676134-7FEEE1F6-8040-4882-BE25-4B1428AA842BQ35698911-AF214B6B-E1D4-4A10-963B-0187EA2A2A8CQ35757055-998210A3-B430-4E89-9118-0372DABEEFECQ35924790-8A30AFD1-1CDC-4AAD-842E-6723A0380965Q36003794-713F4ED1-0B6A-4C67-BD33-87A6329120F1Q36048912-77F3D943-411C-4380-BB32-8093EC981E6AQ36207412-921207F3-3D7A-406C-97AF-5B638B06BB97Q37091891-BA35E4DA-8245-46CD-9AF3-2E4F69ACC725Q37206876-F2C1EFD1-FFAC-472F-8D5B-3C001ACEF622Q37671233-23DC9A5D-4D90-43BC-A3E9-31D160F571F3Q37730682-4CF9D786-A351-498B-8158-FFDE20968877Q37774869-DB2B4E21-6261-4AF8-9047-E5542F13FD29Q37810915-E00DF9F4-AC9A-4705-BA3F-F3AAD5B5BB0EQ37859678-1A3CCCFC-B328-468F-B59A-C791435AAEB7Q37862325-0E8B1EDC-56C5-4354-8E08-338811911111Q37865715-F77186EC-3804-4C26-9E30-8BB3D836CD7FQ37871076-599E5E33-384E-40B5-B6C7-FC197EFC31BEQ37925162-F4561F19-CFB3-4D72-870A-F4242F9A5B94Q38153941-FD16AE64-61F3-4FEB-BB9E-CAF0DC5D8D12Q38390905-64B15D7E-E011-4689-8FC4-0786E0F4CA45Q38666989-2FDC846F-CA40-42FE-AB75-0305502B28E5Q38937744-E56FA1E9-A18D-4615-9356-3465A6446543Q38943183-6F175FFB-108E-400A-8584-473CC10DD10AQ38977666-DDC2BBDF-6FD0-4011-A399-69498A119C1AQ39127509-630453BF-D694-4C6C-8968-DB4098176F98Q39239171-A55BB635-356E-4E95-AB84-C6FF2A948CDFQ40368043-EBF0D6C1-C631-4C78-B29C-732F260CCD15Q40427766-1E8FA5F3-EBDA-4D3E-8D23-168CA8EEE47AQ41593796-290A55B8-0255-4D3A-8993-664E2125C6A0
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Claudia Monaco
@ast
Claudia Monaco
@en
Claudia Monaco
@es
Claudia Monaco
@nl
Claudia Monaco
@sl
type
label
Claudia Monaco
@ast
Claudia Monaco
@en
Claudia Monaco
@es
Claudia Monaco
@nl
Claudia Monaco
@sl
prefLabel
Claudia Monaco
@ast
Claudia Monaco
@en
Claudia Monaco
@es
Claudia Monaco
@nl
Claudia Monaco
@sl
P106
P21
P31
P496
0000-0003-1985-4914